Background Several studies have investigated the value of the systemic immune-
inflammation index (SII) for predicting cardiovascular disease (CVD), but the results were …

Cardiovascular disease (CVD) is the leading cause of death in women, although
traditionally, it has been considered as a male dominated disease. Chronic inflammation …

Background: SII and SIRI are two novel systemic inflammation indexes that were suggested
in predicting poor outcomes in cancers. However, no studies have examined their effect on …

Systemic immune-inflammation index (SII; platelet count× neutrophil-to-lymphocyte ratio), a
novel marker, predicts adverse clinical outcomes in coronary artery diseases (CAD). We …

Objective: In this study, we aimed to explore the association between platelet-to-lymphocyte
ratio (PLR) and the severity of atherosclerosis in coronary artery disease (CAD). Methods …

Background Although a high neutrophil-to-lymphocyte ratio (NLR) has been reported to be a
predictor of poor survival in patients with pancreatic cancers, its prognostic role in patients …

Objective Immune dysregulation influences outcome following acute ischemic stroke (AIS).
Admission white blood cell (WBC) counts are routinely obtained, making the neutrophil …

Background: Atherosclerosis is a chronic systemic inflammatory disease. Neutrophil-to-
lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are systemic inflammatory …

Background Chronic inflammatory disorders in atrial fibrillation (AF) contribute to the onset of
ischemic stroke. Systemic immune inflammation index (SIII) and system inflammation …

The aim of the study was to evaluate the utility of the preprocedural platelet–lymphocyte ratio
(PLR) for predicting no reflow in patients undergoing primary percutaneous intervention …